IgE and risk of cancer in 37 747 individuals from the general population

Annals of Oncology

Volumn 26, Issue 8, 2015, Pages 1784-1790

  Helby, J ^a,b   Bojesen, S E ^a,b,c   Nielsen, S F ^a,b   Nordestgaard, Børge G ^a,b,c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

Allergy; Cancer; Chronic lymphocytic leukemia; Epidemiology; Immunoglobulin E; Multiple myeloma

Indexed keywords

IMMUNOGLOBULIN E;

ADULT; ARTICLE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LOW RISK POPULATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH CANCER; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PHARYNX CANCER; POPULATION RESEARCH; POPULATION RISK; PRIORITY JOURNAL; PROSPECTIVE STUDY; AGED; BLOOD; COHORT ANALYSIS; DENMARK; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LONGITUDINAL STUDY; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASMS; PHARYNGEAL NEOPLASMS; PROPORTIONAL HAZARDS MODEL; PROTECTION; RISK FACTOR;

AGED; COHORT STUDIES; DENMARK; FEMALE; HUMANS; IMMUNOGLOBULIN E; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LONGITUDINAL STUDIES; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; NEOPLASMS; PHARYNGEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RISK FACTORS;

EID: 84941615058     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdv231     Document Type: Article

References (21)

1. Holgate ST. Innate and adaptive immune responses in asthma. Nat Med 2012; 18(5): 673-683.
2. Broide DH. Allergic rhinitis: pathophysiology. Allergy Asthma Proc 2010; 31(5): 370-374.
3. Linneberg A, Nielsen NH, Madsen F et al. Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart: the Copenhagen Allergy Study. J Allergy Clin Immunol 2000; 106(2): 247-252.
4. Gergen PJ, Arbes SJ, Jr, Calatroni A et al. Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol 2009; 124(3): 447-453.
5. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004; 34(4): 520-526.
6. Rittmeyer D, Lorentz A. Relationship between allergy and cancer: an overview. Int Arch Allergy Immunol 2012; 159(3): 216-225.
7. Storm HH. Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol 1988; 17(1): 44-49.
8. Fu SL, Pierre J, Smith-Norowitz TA et al. Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin Exp Immunol 2008; 153(3): 401-409.
9. Berczi I, Holford-Strevens V, Warsi ZH et al. Tumor-reactive IgE antibodies in plasma of patients with gastrointestinal carcinomas. Cancer Immunol Immunother 1983; 14(3): 180-184.
10. Molica S, Levato D, Dell'Olio M et al. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis. Haematologica 1996; 81(5): 428-433.
11. Geisler CH, Larsen JK, Hansen NE et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991; 78(7): 1795-1802.
12. Luo HY, Hofstetter H, Banchereau J, Delespesse G. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. J Immunol 1991; 146(7): 2122-2129.
13. Ellison-Loschmann L, Benavente Y, Douwes J et al. Immunoglobulin E levels and risk of lymphoma in a case-control study in Spain. Cancer Epidemiol Biomarkers Prev 2007; 16(7): 1492-1498.
14. Nieters A, Luczynska A, Becker S et al. Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myelomaresults of the European Prospective Investigation into Cancer and Nutrition. Carcinogenesis 2014; 35(12): 2716-2722.
15. Melbye M, Smedby KE, Lehtinen T et al. Atopy and risk of non-Hodgkin lymphoma. J Natl Cancer Inst 2007; 99(2): 158-166.
16. Lindelof B, Granath F, Tengvall-Linder M, Ekbom A. Allergy and cancer. Allergy 2005; 60(9): 1116-1120.
17. Turner MC, Chen Y, Krewski D et al. Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol 2005; 162(3): 212-221.
18. Friedrich N, Husemoen LL, Petersmann A et al. The association between alcohol consumption and biomarkers of alcohol exposure with total serum immunoglobulin E levels. Alcohol Clin Exp Res 2008; 32(6): 983-990.
19. Andreotti G, Birmann B, de Roos AJ et al. A pooled analysis of alcohol consumption and risk of multiple myeloma in the international multiple myeloma consortium. Cancer Epidemiol Biomarkers Prev 2013; 22(9): 1620-1627.
20. Morton LM, Slager SL, Cerhan JR et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 2014; 2014(48): 130-144.
21. Pien GC, Orange JS. Evaluation and clinical interpretation of hypergammaglobulinemia E: differentiating atopy from immunodeficiency. Ann Allergy Asthma Immunol 2008; 100(4): 392-395.